HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inga Koneczny Selected Research

Rhabdomyosarcoma

10/2017Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Inga Koneczny Research Topics

Disease

17Myasthenia Gravis
01/2024 - 12/2012
7Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2018
4Thrombotic Thrombocytopenic Purpura
01/2022 - 01/2018
4Pemphigus (Pemphigus Vulgaris)
01/2022 - 01/2018
3Genetic Predisposition to Disease (Genetic Predisposition)
01/2022 - 01/2020
3Immunoglobulin G4-Related Disease
01/2022 - 10/2020
3Neoplasms (Cancer)
10/2020 - 01/2011
2Autoimmune Diseases of the Nervous System
01/2020 - 01/2018
2Thymoma (Thymic Carcinoma)
01/2018 - 12/2012
2Arthrogryposis
10/2017 - 12/2012
1Tauopathies
10/2023
1Nervous System Diseases (Neurological Disorders)
01/2023
1Disease Progression
01/2022
1Immune System Diseases (Immune Disorders)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Nephrotic Syndrome (Syndrome, Nephrotic)
01/2021
1Rare Diseases (Rare Disease)
01/2021
1Infections
10/2020
1Rheumatoid Arthritis
10/2020
1Hypersensitivity (Allergy)
10/2020
1Glomerulonephritis
01/2020
1Muscle Weakness
01/2020
1Multiple Sclerosis
01/2018
1Peripheral Nervous System Diseases (PNS Diseases)
01/2018
1Epstein-Barr Virus Infections
01/2018
1Relapsing-Remitting Multiple Sclerosis
01/2018
1Rhabdomyosarcoma
10/2017
1Adenoma (Adenomas)
09/2015
1Neuromyelitis Optica (Devic's Disease)
12/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2011

Drug/Important Bio-Agent (IBA)

16AutoantibodiesIBA
01/2024 - 01/2013
12AntibodiesIBA
01/2021 - 12/2012
11Immunoglobulin G (IgG)IBA
01/2024 - 01/2013
9muskIBA
01/2024 - 12/2012
6Phosphotransferases (Kinase)IBA
01/2024 - 12/2012
6Cholinergic ReceptorsIBA
01/2020 - 12/2012
4AntigensIBA
01/2022 - 01/2018
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2014 - 12/2012
2Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2022
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2020
1peripheral membrane protein 43KIBA
01/2020
1Rituximab (Mabthera)FDA Link
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2018
1Cholecalciferol (Vitamin D3)FDA Link
01/2018
1ConnectinIBA
01/2018
1Vitamin DFDA LinkGeneric
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1CortactinIBA
01/2018
1Monoclonal AntibodiesIBA
10/2017
1Indicators and Reagents (Reagents)IBA
10/2017
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2017
1EpitopesIBA
01/2017
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
01/2017
1fibroblast growth factor 18IBA
09/2015
1AgrinIBA
01/2013
1Immunoglobulin Fab FragmentsIBA
01/2013
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2011
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2011

Therapy/Procedure

2Therapeutics
01/2024 - 01/2022